Navis GJ - Search Results

1

A Self-management Approach for Dietary Sodium Restriction in Patients With CKD: A Randomized Controlled Trial.

Humalda JK, Klaassen G, de Vries H, Meuleman Y, Verschuur LC, Straathof EJM, Laverman GD, Bos WJW, van der Boog PJM, Vermeulen KM, Blanson Henkemans OA, Otten W, de Borst MH, van Dijk S, Navis GJ; SUBLIME Investigators. Humalda JK, et al. Among authors: navis gj. Am J Kidney Dis. 2020 Jun;75(6):847-856. doi: 10.1053/j.ajkd.2019.10.012. Epub 2020 Jan 16. Am J Kidney Dis. 2020. PMID: 31955921 Clinical Trial.

2

Optimal antiproteinuric dose of losartan in nondiabetic patients with nephrotic range proteinuria.

Laverman GD, Henning RH, de Jong PE, Navis G, de Zeeuw D. Laverman GD, et al. Am J Kidney Dis. 2001 Dec;38(6):1381-4. doi: 10.1053/ajkd.2001.29262. Am J Kidney Dis. 2001. PMID: 11728979 Clinical Trial.

3

Short-term moderate sodium restriction induces relative hyperfiltration in normotensive normoalbuminuric Type I diabetes mellitus.

Luik PT, Hoogenberg K, Van Der Kleij FG, Beusekamp BJ, Kerstens MN, De Jong PE, Dullaart RP, Navis GJ. Luik PT, et al. Among authors: navis gj. Diabetologia. 2002 Apr;45(4):535-41. doi: 10.1007/s00125-001-0763-8. Diabetologia. 2002. PMID: 12032630 Clinical Trial.

4

Dual renin-angiotensin system blockade at optimal doses for proteinuria.

Laverman GD, Navis G, Henning RH, de Jong PE, de Zeeuw D. Laverman GD, et al. Kidney Int. 2002 Sep;62(3):1020-5. doi: 10.1046/j.1523-1755.2002.00536.x. Kidney Int. 2002. PMID: 12164886 Free article. Clinical Trial.

5

Renoprotective effects of VPI versus ACEI in normotensive nephrotic rats on different sodium intakes.

Laverman GD, Van Goor H, Henning RH, De Jong PE, De Zeeuw D, Navis G. Laverman GD, et al. Kidney Int. 2003 Jan;63(1):64-71. doi: 10.1046/j.1523-1755.2003.00708.x. Kidney Int. 2003. PMID: 12472769 Free article.

6

Between-patient differences in the renal response to renin-angiotensin system intervention: clue to optimising renoprotective therapy?

Laverman GD, de Zeeuw D, Navis G. Laverman GD, et al. J Renin Angiotensin Aldosterone Syst. 2002 Dec;3(4):205-13. doi: 10.3317/jraas.2002.042. J Renin Angiotensin Aldosterone Syst. 2002. PMID: 12584664 Free article. Review.

7

The COOPERATE trial.

Vogt L, Laverman GD, de Zeeuw D, Navis G. Vogt L, et al. Lancet. 2003 Mar 22;361(9362):1055-6. doi: 10.1016/S0140-6736(03)12803-6. Lancet. 2003. PMID: 12660079 No abstract available.

8

A central body fat distribution is related to renal function impairment, even in lean subjects.

Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE; PREVEND Study Group. Pinto-Sietsma SJ, et al. Am J Kidney Dis. 2003 Apr;41(4):733-41. doi: 10.1016/s0272-6386(03)00020-9. Am J Kidney Dis. 2003. PMID: 12666059

9

Involvement of renal ACE activity in proteinuria-associated renal damage in untreated and treated adriamycin nephrotic rats.

Bos H, Laverman GD, Henning RH, Tiebosch AT, de Jong PE, de Zeeuw D, Navis G. Bos H, et al. J Renin Angiotensin Aldosterone Syst. 2003 Jun;4(2):106-12. doi: 10.3317/jraas.2003.010. J Renin Angiotensin Aldosterone Syst. 2003. PMID: 12806593 Free article.

10

Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage.

Kramer AB, Laverman GD, van Goor H, Navis G. Kramer AB, et al. J Pathol. 2003 Sep;201(1):160-7. doi: 10.1002/path.1405. J Pathol. 2003. PMID: 12950029

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

766 results

Search Page

Filters